A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation.

Area of Science:

• Oncology
• Molecular Biology
• Urological Cancer Research

Background:

• Bladder cancer is a prevalent urological malignancy with high mortality and limited diagnostic/treatment advancements.
• Early diagnosis remains a challenge, significantly impacting patient survival rates worldwide.

Purpose of the Study:

• To identify novel therapeutic biomarkers for improved bladder cancer treatment.
• To investigate the role of ZNF485 in bladder cancer progression.

Main Methods:

• Analysis of TCGA database for bladder cancer sequencing data, clinicopathological features, and survival information.
• Experimental validation of ZNF485 expression in cell lines, animal models, and human tissue microarrays.
• Functional assays including proliferation, apoptosis, wound healing, and invasion assays; in vivo tumor growth studies in nude mice.

Main Results:

• ZNF485 was found to be highly expressed in bladder cancer tissues and cell lines.
• Inhibition of ZNF485 significantly reduced bladder cancer cell proliferation and induced apoptosis.
• Downregulation of ZNF485 decreased cancer cell mobility and invasion, and inhibited tumor growth in vivo.
• Mechanistic analysis suggested potential downstream target genes involved in ZNF485 function.

Conclusions:

• ZNF485 plays a crucial role in promoting bladder cancer proliferation, migration, and invasion.
• ZNF485 is a potential therapeutic biomarker for bladder cancer.
• Further research into ZNF485's downstream targets may reveal new therapeutic strategies.